Companies Securities and Exchange Commission (SEC) Shareholders 
The Motley Fool
DECEMBER 3, 2024
In case you missed it, institutional funds recently disclosed their latest equity holdings for the third quarter of the year in their 13F forms filed with the Securities and Exchange Commission (SEC). Warren Buffett's company Berkshire Hathaway has been buying shares all year. Could they be onto something?
The Motley Fool
FEBRUARY 13, 2024
CrowdStrike brings superior artificial intelligence to endpoint security software CrowdStrike is a cybersecurity software vendor. Its platform integrates more than two dozen modules that address multiple security end markets. First, CEO George Kurtz says most enterprises still buy more than 60 security point products.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Motley Fool
JUNE 20, 2023
Bankruptcy is a word no investor wants to hear, with shareholders generally wiped out in the restructuring process. No public company is really looking to go down the bankruptcy path, which is why it is so important for investors to pay attention when one warns that bankruptcy is a very real possibility. The outlook doesn't look good.
The Motley Fool
APRIL 29, 2024
The company just filed an amended 10-K annual report with the U.S. Securities and Exchange Commission (SEC), giving investors its latest up-to-date numbers on how it looks post-merger. While nominally profitable, this lithium miner currently isn't generating any free cash flow for its shareholders.
The Motley Fool
OCTOBER 20, 2024
So when the billionaire investor makes substantive changes in his company's key holdings, people pay attention. The latest sale is particularly interesting The Securities and Exchange Commission (SEC) requires large shareholders -- investors owning more than 10% of a company's stock -- to report any trade within two business days.
The Motley Fool
JUNE 15, 2023
The company's meteoric rise has been fueled by the Food and Drug Administration (FDA) approval of the major depressive disorder drug Auvelity (AXS-05), as well as the acquisition of the narcolepsy medication Sunosi from Jazz Pharmaceuticals. On the high end, the company's leadership thinks Auvelity and Sunosi could hit a whopping $3.5
The Motley Fool
JANUARY 30, 2024
A lot has been made of the slew of new spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) that came to the market earlier this month. There may be some hidden opportunities for some companies to make money off these new funds despite not being front and center when it comes to issuing and marketing these ETFs.
Expert insights. Personalized for you.
241 
Let's personalize your content